Edesa Biotech, Inc. Recorded Big Gain

Edesa Biotech, Inc. (EDSA:NASDAQ) rocketted at $6.52, representing a gain of 80.6%. On Fri, Mar 06, 2026, EDSA:NASDAQ hit a New 2-Week High of $6.52. The stock appeared on our News Catalysts scanner on Mon, Mar 02, 2026 at 12:36 PM in the 'BIOTECH' category. From Fri, Feb 20, 2026, the stock recorded 70.00% Up Days and 63.64% Green Days

About Edesa Biotech, Inc. (EDSA:NASDAQ)

Stellar Biotechnologies Inc is a biotechnology company. The company is engaged in the aquaculture, research, and development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein with an extensive history of safe and effective use in immunological applications. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-targeting agent to create immunotherapies for the treatment of a variety of diseases. It derives its revenues mostly from Europe. Stellar primarily market and distribute products directly to biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers.